PC Pharma PLC reported unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported revenue of LKR 122,257,395 compared to LKR 150,918,097 a year ago. Profit from operating activities was LKR 15,399,542 compared to LKR 38,213,695 a year ago. Profit before tax was LKR 4,570,613 compared to LKR 31,554,440 a year ago. Profit for the period was LKR 3,290,841 or LKR 0.03 per share compared to LKR 22,719,197 or LKR 0.22 per share a year ago.

For the period, the company reported revenue of LKR 439,978,570 compared to LKR 474,772,352 a year ago. Profit from operating activities was LKR 63,368,946 compared to LKR 164,844,575 a year ago. Profit before tax was LKR 33,099,994 compared to LKR 146,413,504 a year ago. Profit for the period was LKR 23,831,996 or LKR 0.24 per share compared to LKR 105,417,723 or LKR 1.04 per share a year ago. Net cash from operating activities was LKR 68,332,206 compared to net cash used in operating activities of LKR 30,481,719 a year ago. Purchases of property, plant and equipment was LKR 141,420 compared to LKR 449,277 a year ago.